NASDAQ:SOLY - Soliton Stock Price, Forecast & News

Soliton trades on the NASDAQ under the ticker symbol "SOLY."

1 brokers have issued 1 year target prices for Soliton's stock. Their forecasts range from $22.00 to $22.00. On average, they expect Soliton's share price to reach $22.00 in the next year. This suggests a possible upside of 63.0% from the stock's current price. View Analyst Price Targets for Soliton.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Soliton in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Soliton.

News stories about SOLY stock have trended positive recently, according to InfoTrie Sentiment. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Soliton earned a media sentiment score of 2.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Soliton.

Soliton saw a decrease in short interest in the month of December. As of December 31st, there was short interest totalling 1,130,000 shares, a decrease of 5.0% from the December 15th total of 1,190,000 shares. Based on an average trading volume of 236,300 shares, the days-to-cover ratio is presently 4.8 days. Approximately 17.8% of the shares of the stock are sold short. View Soliton's Current Options Chain.

Some companies that are related to Soliton include Orthopediatrics (KIDS), Intersect ENT (XENT), LeMaitre Vascular (LMAT), Anika Therapeutics (ANIK), Antares Pharma (ATRS), AngioDynamics (ANGO), Cerus (CERS), SurModics (SRDX), SI-Bone (SIBN), OraSure Technologies (OSUR), Alphatec (ATEC), MiMedx Group (MDXG), Utah Medical Products (UTMD), Delcath Systems (DCTH) and Inovio Pharmaceuticals (INO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Soliton investors own include Cronos Group (CRON), NVIDIA (NVDA), Micron Technology (MU), Aurora Cannabis (ACB), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), Square (SQ), Crius Energy Unt (KWH.UN), Advanced Micro Devices (AMD) and Amarin (AMRN).

Shares of SOLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SOLY stock can currently be purchased for approximately $13.50.

Soliton has a market capitalization of $228.58 million. Soliton employs 7 workers across the globe.View Additional Information About Soliton.

The official website for Soliton is http://www.soliton.com/.

Soliton's mailing address is 5304 ASHBROOK DRIVE, HOUSTON TX, 77081. The company can be reached via phone at 844-705-4866.